Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer
Conditions: Postmenopausal; Breast Cancer Interventions: Other: Acupressure; Other: Acupressure Sponsors: University of Michigan Rogel Cancer Center; Breast Cancer Research Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer
Conditions: Breast Cancer; Triple Negative Breast Cancer Interventions: Drug: Adebrelimab; Drug: Vinorelbine; Drug: Cyclophosphamide (tablet); Drug: Capecitabine Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.
Conditions: Non Small Cell Lung Cancer; Breast Cancer; Colorectal Cancer; Gastric Cancer; Liver Cancer; Advanced Cancer; Immune Checkpoint Inhibitor Sponsors: Gene Solutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing Study
Conditions: Breast Cancer Interventions: Drug: Indocyanine green Sponsors: Jules Bordet Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
Biofeedback Training on Shoulder Muscles Strength Post Mastectomy
Conditions: Breast Cancer Female Interventions: Procedure: Biofeedback device and other group control group; Procedure: Control group Sponsors: Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
Early Detection of Triple Negative Breast Cancer Relapse
Conditions: Triple Negative Breast Cancer Interventions: Diagnostic Test: ctDNA monitoring; Diagnostic Test: 68Ga-FAPI-46-PET-CT Sponsors: Institut Curie; National Research Agency, France; Roche Pharma AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Study of DV Plus Toripalimab in Combination or Sequence With Chemotherapy in HR-negative, HER2 Low-expressing Breast Cancer
Conditions: Breast Cancer Interventions: Drug: Disitamab Vedotin Injection （18 weeks）; Drug: Toripalimab （18weeks）; Drug: Carboplatin; Drug: Disitamab Vedotin Injection （12 weeks）; Drug: Sequential Epirubicin; Drug: Sequential CTX; Drug: Toripalimab （12weeks） Sponsors: RemeGen Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
SPSIPB for Breast Cancer Surgery
Conditions: Pain, Postoperative; Pain, Acute; Opioid Consumption Interventions: Procedure: Serratus posterior superior intercostal plane block Sponsors: Zonguldak Bulent Ecevit University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients
Conditions: Breast Neoplasms; Breast Cancer Interventions: Radiation: Ten-fraction hypofractionated breast radiotherapy with 40 Gy simultaneous integrated bed boost; Radiation: Ten-fraction hypofractionated breast radiotherapy with 43 Gy simultaneous integrated bed boost Sponsors: Regina Elena Cancer Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
The Effects of HER2 Receptor Signaling on Human Brown Fat Activity
Conditions: Breast Cancer Interventions: Other: None (Observational study) Sponsors: Rigshospitalet, Denmark Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer PAINT)
Conditions: Breast Cancer Interventions: Device: Convertible Plasma Jet Sponsors: Centre hospitalier de l ' Universit é de Montréal (CHUM); Ozmosis Research Inc.; Ministère de l ' Économie, de l ' Innovation et de l ' Énergie, Québec, Canada; Quebec Breast Cancer Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients
Conditions: Triple Negative Breast Cancer; Premenopausal Breast Cancer Interventions: Drug: Goserelin Acetate 3.6mg 、Goserelin Acetate 10.8mg、Leuprolide Acetate 3.75mg、Leuprorelin Acetate 22.5mg、Triptorelin pamoate 11.25mg、Triptorelin pamoate 22.5mg Sponsors: National Taiwan University Hospital; Ministry of Health and Welfare; Debiopharm International SA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
Conditions: HER2 Low Breast Carcinoma; Triple Negative Breast Cancer; Hormone-receptor-positive Breast Cancer; Hormone Receptor Positive Breast Carcinoma Interventions: Drug: ARX788; Procedure: Computed Tomography (CT); Procedure: Biospecimen Collection Sponsors: Laura Huppert, MD, BA; Ambrx, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
The Effect of Music on Pain, Anxiety and Satisfaction During Mammography
Conditions: Breast Cancer; Pain; Anxiety Interventions: Other: Music therapy Sponsors: Saglik Bilimleri Universitesi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer
Conditions: Breast Cancer Interventions: Drug: Letrozole; Drug: Anastrozole; Drug: Exemestane; Drug: Tamoxifen Sponsors: Region Örebro County; Mid-Sweden Regional Cancer Centre; Akademiska University Hospital, Uppsala, Sweden Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
